Literature DB >> 10050246

Nonoperative treatment of Dupuytren's disease.

L C Hurst1, M A Badalamente.   

Abstract

Many nonoperative therapies have been investigated for the treatment of Dupuytren's disease. These include needle fasciotomy, continuous slow skeletal traction, radiation, dimethyl sulfoxide, vitamin E, allopurinol, physical therapy, ultrasound therapy, steroid injections, radiation, interferon, splinting, and enzymatic fasciotomy. Most of these therapies have not proven to be clinically useful. However, recent investigation of enzymatic fasciotomy using collagenase injection has shown encouraging results.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10050246

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  15 in total

1.  Injectable collagenase Clostridium histolyticum as a nonsurgical treatment for Dupuytren's disease.

Authors:  R Arora; P Kaiser; T-J Kastenberger; G Schmiedle; S Erhart; M Gabl
Journal:  Oper Orthop Traumatol       Date:  2015-12-18       Impact factor: 1.154

2.  Connective tissue diseases: A nonsurgical therapy for Dupuytren disease.

Authors:  Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

3.  Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature.

Authors:  Keith Denkler
Journal:  Eplasty       Date:  2010-01-27

4.  Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.

Authors:  Latha Satish; David B O'Gorman; Sandra Johnson; Christina Raykha; Bing Siang Gan; James H-C Wang; Sandeep Kathju
Journal:  Cell Stress Chaperones       Date:  2013-01-06       Impact factor: 3.667

5.  [Treatment of Dupuytren's disease with collagenase Clostridium histolyticum].

Authors:  M Keller; R Arora; G Schmiedle; T Kastenberger
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

6.  Collagenase Use and a Trap for the Unwary in Patients With Upper Limb Spasticity.

Authors:  Suzanne M Beecher; Billy Lane O'Neill; Michael O'Shaughnessy
Journal:  Hand (N Y)       Date:  2020-01-09

7.  Seven-year clinical outcomes after collagenase injection in patients with Dupuytren's disease: A prospective study.

Authors:  Rocco De Vitis; Marco Passiatore; Andrea Perna; Silvia Careri; Vitale Cilli; Giuseppe Taccardo
Journal:  J Orthop       Date:  2020-03-29

8.  The Surgical Release of Dupuytren's Contracture Using Multiple Transverse Incisions.

Authors:  Hyunjic Lee; Surak Eo; Sanghun Cho; Neil F Jones
Journal:  Arch Plast Surg       Date:  2012-07-13

9.  Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.

Authors:  Latha Satish; Phillip H Gallo; Mark E Baratz; Sandra Johnson; Sandeep Kathju
Journal:  BMC Musculoskelet Disord       Date:  2011-05-25       Impact factor: 2.362

10.  Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.

Authors:  Latha Satish; William A LaFramboise; Sandra Johnson; Linda Vi; Anna Njarlangattil; Christina Raykha; John Michael Krill-Burger; Phillip H Gallo; David B O'Gorman; Bing Siang Gan; Mark E Baratz; Garth D Ehrlich; Sandeep Kathju
Journal:  BMC Med Genomics       Date:  2012-05-04       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.